Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The gastrointestinal epithelium refers to the single-layered lining of the GI tract, comprising several specialized cell types including enterocytes (nutrient absorption), goblet cells (mucus secretion), Paneth cells (antimicrobial peptide secretion), and enteroendocrine cells (hormone production)[3][5][6]. Its main functions include enabling nutrient uptake, acting as a physical and chemical barrier to pathogens, and mediating immune responses[1][3][5][7]. The epithelium is highly dynamic, renewing rapidly through stem cell division and differentiation, and it adapts to various insults (inflammation, infection, metabolic stress, environmental changes)[5][6][7]. It is closely involved in digestive health and disease, acting as a key interface between the body and the external environment (food, microbes, toxins), but it is not a druggable molecular target by itself; rather, drugs target specific proteins, receptors, or signaling pathways within epithelial cells.
Not applicable; mechanisms depend on specific molecular targets within the epithelium (e.g., blockade of sodium-glucose transporter for diabetes).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gastrointestinal epithelium.